Early loss of CREBBP confers malignant stem cell properties on lymphoid progenitors by Huntly, B, Horton, S, Giotopoulos, G, Yun, H, Vohra, S, Sheppard, O, Bashford-Rogers, R, Rashid, M, Sasca, D, Basheer, F, Gallipoli, P, Okosun, J, Hodson, D, Fitzgibbon, J, Du, M, Adams, D

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors by Horton, S, Giotopoulos, G, Yun, H, Vohra, S, Sheppard, O, Bashford-Rogers, R, Rashid, M, Clipson, A, Chan, W, Sasca, D, Yiangou, L, Osaki, H, Basheer, F, Gallipoli, P, Burrows, N, Erdem, A, Sybirna, A, Foerster, S, Zhao, W, Sustic, T, Petrunkina Harrison, A, Laurenti, E, Okosun, J, Hodson, D, Wright, P, Smith, K, Maxwell, P, Fitzgibbon, J, Du, M, Adams, D, Huntly, B

Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP by Wiseman, F, Pulford, L, Barkus, C, Liao, F, Portelius, E, Webb, R, Chávez-Gutiérrez, L, Cleverley, K, Noy, S, Sheppard, O, Collins, T, Powell, C, Sarell, C, Rickman, M, Choong, X, Tosh, J, Siganporia, C, Whittaker, H, Stewart, F, Szaruga, M, London Down Syndrome Consortium, Murphy, M, Blennow, K, De Strooper, B, Zetterberg, H, Bannerman, D, Holtzman, D, Tybulewicz, V, Fisher, E, LonDownS Consortium